Systematic pulmonary embolism follow-up increases diagnostic rates of chronic thromboembolic pulmonary hypertension and identifies less severe disease: results from the ASPIRE Registry.
Charlotte DurringtonJudith A HurdmanCharlie A ElliotRhona MacleanJoost Van VeenGiorgia SacculloDuneesha De-FoneskaAndrew J SwiftRajaram SmithaCatherine HillSteven ThomasKrit DwivediSamer AlabedJames M WildAthanasios CharalampopoulosAbdul G HameedAlexander M K RothmanLisa WatsonNeil HamiltonAlfred Arthur Roger ThompsonRobin CondliffeDavid G KielyPublished in: The European respiratory journal (2024)
In the real-world setting a dedicated PE follow-up pathway identifies patients with less severe CTEPH and increases population-based CTEPH diagnostic and PEA rates. At the time of acute PE diagnosis the absence of major transient risk factors, CT features of PH and chronic thromboembolism are risk factors for a subsequent diagnosis of CTEPH.
Keyphrases
- pulmonary embolism
- drug induced
- pulmonary hypertension
- risk factors
- inferior vena cava
- genome wide
- early onset
- liver failure
- pulmonary artery
- atrial fibrillation
- magnetic resonance imaging
- pulmonary arterial hypertension
- gene expression
- magnetic resonance
- intensive care unit
- contrast enhanced
- cerebral ischemia
- brain injury
- subarachnoid hemorrhage